I agree that this site is using cookies. You can find further informations here.
X
Rivella, Stefano
230  results:
Search for persons X
?
1

Combination of a TGF‐β ligand trap (RAP‐GRL) and TMPRSS6‐AS..:

Guerra, Amaliris ; Hamilton, Nolan ; Rivera, Ariel...
American Journal of Hematology.  99 (2024)  7 - p. 1300-1312 , 2024
Link: https://doi.org/10.1002/..
 
?
2

Iron restriction in sickle cell disease: When less is more:

Castro, Oswaldo L. ; De Franceschi, Lucia ; Ganz, Tomas...
American Journal of Hematology.  99 (2024)  7 - p. 1349-1359 , 2024
Link: https://doi.org/10.1002/..
 
?
3

Optimizing lentiviral genomic integrations to cure beta-tha..:

Rivella, Stefano
Molecular Therapy - Methods & Clinical Development.  32 (2024)  1 - p. 101222 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Single vs. dual transgenegene therapy for multiple sulfatas..:

Pham, Vi ; Tricoli, Lucas ; Wongkittichote, Parith...
Molecular Genetics and Metabolism.  141 (2024)  2 - p. 107996 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Normal and dysregulated crosstalk between iron metabolism a..:

Ginzburg, Yelena ; An, Xiuli ; Rivella, Stefano.
eLife.  12 (2023)  - p. , 2023
Link: https://doi.org/10.7554/..
 
?
6

In vivo hematopoietic stem cell modification by mRNA delive..:

Breda, Laura ; Papp, Tyler E. ; Triebwasser, Michael P....
Science.  381 (2023)  6656 - p. 436-443 , 2023
Link: https://doi.org/10.1126/..
 
?
7

Elevated CDKN1A (P21) mediates β-thalassemia erythroid apop..:

Liang, Raymond ; Lin, Miao ; Menon, Vijay...
Blood Advances.  7 (2023)  22 - p. 6873-6885 , 2023
Link: https://doi.org/10.1182/..
 
?
8

TMPRSS6 as a Therapeutic Target for Disorders of Erythropoi..:

Ganz, Tomas ; Nemeth, Elizabeta ; Rivella, Stefano...
Advances in Therapy.  40 (2023)  4 - p. 1317-1333 , 2023
Link: https://doi.org/10.1007/..
 
?
9

Novel potential therapeutics to modify iron metabolism and ..:

Guerra, Amaliris ; Parhiz, Hamideh ; Rivella, Stefano
Haematologica.  108 (2023)  10 - p. 2582-2593 , 2023
Link: https://doi.org/10.3324/..
 
?
10

Optimizing cross-correction to overcome limitations ofgene ..:

Pham, Vi ; Tricoli, Lucas ; Schlotawa, Lars..
Molecular Genetics and Metabolism.  138 (2023)  2 - p. 107267 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Protocol for a high titer of BaEV-Rless pseudotyped lentivi..:

Noguchi, Kazuhiro ; Ikawa, Yasuhiro ; Takenaka, Mika...
Journal of Virological Methods.  314 (2023)  - p. 114689 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Transferrin receptor 2 (Tfr2) genetic deletion makes transf..:

Di Modica, Simona Maria ; Tanzi, Emanuele ; Olivari, Violante...
American Journal of Hematology.  97 (2022)  10 - p. 1324-1336 , 2022
Link: https://doi.org/10.1002/..
 
?
13

Emergent treatments for β-thalassemia and orphan drug legis..:

Costa, Enrico ; Cappellini, Maria Domenica ; Rivella, Stefano...
Drug Discovery Today.  27 (2022)  11 - p. 103342 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Tmprss6-ASO as a tool for the treatment of Polycythemia Ver..:

Casu, Carla ; Liu, Alison ; De Rosa, Gianluca...
PLOS ONE.  16 (2021)  12 - p. e0251995 , 2021
Link: https://doi.org/10.1371/..
 
?
15

Increased CFTR expression and function from an optimized le..:

Marquez Loza, Laura I. ; Cooney, Ashley L. ; Dong, Qian...
Molecular Therapy - Methods & Clinical Development.  21 (2021)  - p. 94-106 , 2021
Link: https://doi.org/10.1016/..
 
1-15